At last, we confirmed the relevance of RUNX2 transcriptional regulation in vivo in two independent retrospective cohorts of 48 TC and 79 BC patients, showing that SREBF1 is overexpressed in TCs and BCs that developed distant metastases. This evidence concerns the gene RUNX2 and breast cancer.